Cite
APA Citation
Gogas, H., Gutzmer, R., Malvehy, J., Mehnert, J. M., Liu, K., Pickett, C. A., Snyder, W., & Chesney, J. (n.d.). 60PResponse rates with talimogene laherparepvec (T-VEC) monotherapy in patients (pts) with stage IIIB–IVM1c melanoma previously treated with checkpoint inhibitor (CPI) therapy: Retrospective analysis of two clinical trials. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095518057.0x000045